Suchergebnisse

346 Artikel wurden gefunden.

Die folgenden Begriffe wurden einbezogen: Glioblastom, glioblastoma, 神経膠細胞芽腫

• 2016, Chamberlain MC
  Treatment for Patients With Newly Diagnosed Glioblastoma [Kommentar]
  JAMA 315 (21): 2348
• 2016, Chan AK, Birk HS, Winkler EA, Viner JA, Taylor JW, McDermott MW
  Stability of programmable shunt valve settings with simultaneous use of the Optune transducer array: a case report [Gerät/Impl.]
  Cureus 8 (7): e675-
• 2018, Chang E, Patel CB, Pohling C, Young C, Song J, Flores TA, Zeng Y, Joubert LM, Arami H, Natarajan A, Sinclair R, Gambhir SS
  Tumor treating fields increases membrane permeability in glioblastoma cells [med./bio.]
  Cell Death Discov 4: 113
• 2017, Chang E, Pohling C, Beygui N, Patel CB, Rosenberg J, Ha DH, Gambhir SS
  Synergistic inhibition of glioma cell proliferation by Withaferin A and tumor treating fields [med./bio.]
  J Neurooncol 134 (2): 259-268
• 2024, Chang HF, Cheng JY
  Glioblastoma U-87 cell electrotaxis is hindered by doxycycline with a concomitant reduction in the matrix metallopeptidase-9 expression [med./bio.]
  Biochem Biophys Rep 38: 101690
• 2007, Chatti S, Debbabi F, Guesmi H, El Maalel O, Baccouche N, Krifa H, Mrizak N
  [Study of occupational exposure in patients with primary malignant brain tumours] [fremdsprachig]
  Arch Mal Prof Environ 68 (5-6): 572-578
• 2015, Chaudhry A, Benson L, Varshaver M, Farber O, Weinberg U, Kirson E, Palti Y
  NovoTTF-100A system (Tumor Treating Fields) transducer array layout planning for glioblastoma: a NovoTAL system user study [med. Anw.]
  World J Surg Oncol 13: 316
• 2007, Chauhan V, Qutob SS, Lui S, Mariampillai A, Bellier PV, Yauk CL, Douglas GR, Williams A, McNamee JP
  [Details] Analysis of gene expression in two human-derived cell lines exposed in vitro to a 1.9 GHz pulse-modulated radiofrequency field [med./bio.]
  Proteomics 7 (21): 3896-3905
• 2024, Chen D, Le SB, Manektalia H, Liu T, Hutchinson TE, O'Dell A, Salhia B, Tran DD
  The EP3-ZNF488 Axis Promotes Self-Renewal of Glioma Stem-like Cells to Induce Resistance to Tumor Treating Fields [med./bio.]
  Cancer Res [im Druck]
• 2022, Chen D, Le SB, Hutchinson TE, Calinescu AA, Sebastian M, Jin D, Liu T, Ghiaseddin A, Rahman M, Tran DD
  Tumor Treating Fields dually activate STING and AIM2 inflammasomes to induce adjuvant immunity in glioblastoma [med./bio.]
  J Clin Invest 132 (8): e149258
• 2024, Chen J, Liu Y, Lan J, Liu H, Tang Q, Li Z, Qiu X, Hu W, Xie J, Feng Y, Qin L, Zhang X, Liu J, Chen L
  Identification and validation of COL6A1 as a novel target for tumor electric field therapy in glioblastoma [med./bio.]
  CNS Neurosci Ther 30 (6): e14802
• 2021, Choi KH, Ha J, Bae S, Lee AK, Choi HD, Ahn YH, Ha M, Joo H, Kwon HJ, Jung KW
  Mobile Phone Use and Time Trend of Brain Cancer Incidence Rate in Korea [epidem.]
  Bioelectromagnetics 42 (8): 629-648
• 2017, Cifuentes-Rius A, Ivask A, Das S, Penya-Auladell N, Fabregas L, Fletcher NL, Houston ZH, Thurecht KJ, Voelcker NH
  Gold Nanocluster-Mediated Cellular Death under Electromagnetic Radiation [med./bio.]
  ACS Appl Mater Interfaces 9 (47): 41159-41167
• 2021, Clancy H, Pruski M, Lang B, Ching J, McCaig CD
  Glioblastoma Cell Migration is Directed by Electrical Signals [med./bio.]
  Exp Cell Res 406 (1): 112736
• 2017, Clark PA, Gaal JT, Strebe JK, Pasch CA, Deming DA, Kuo JS, Robins HI
  The effects of tumor treating fields and temozolomide in MGMT expressing and non-expressing patient-derived glioblastoma cells [med./bio.]
  J Clin Neurosci 36: 120-124
• 2017, Cloughesy TF, Lassman AB
  NovoTTF: where to go from here? [Kommentar]
  Neuro Oncol 19 (5): 605-608
• 2019, Cobbs C, McClay E, Duic JP, Nabors LB, Morgan DM, Kesari S
  An early feasibility study of the Nativis Voyager® device in patients with recurrent glioblastoma: first cohort in US [med. Anw.]
  CNS Oncol 8 (1): CNS30
• 2009, Coble JB, Dosemeci M, Stewart PA, Blair A, Bowman J, Fine HA, Shapiro WR, Selker RG, Loeffler JS, Black PM, Linet MS, Inskip PD
  [Details] Occupational exposure to magnetic fields and the risk of brain tumors [epidem.]
  Neuro Oncol 11 (3): 242-249
• 2020, Crawford J, Saria MG, Dhall G, Margol A, Kesari S
  Feasibility of Treating High Grade Gliomas in Children with Tumor-Treating Fields: A Case Series [med. Anw.]
  Cureus 12 (10): e10804
• 2023, Cruz N, Herculano-Carvalho M, Roque D, Faria CC, Cascão R, Ferreira HA, Reis CP, Matela N
  Highlighted Advances in Therapies for Difficult-To-Treat Brain Tumours Such as Glioblastoma [Review]
  Pharmaceutics 15 (3): 928
• 2013, Davies AM, Weinberg U, Palti Y
  Tumor treating fields: a new frontier in cancer therapy [med. Anw.]
  Ann N Y Acad Sci 1291: 86-95
• 2020, Davis FG, Smith TR, Gittleman HR, Ostrom QT, Kruchko C, Barnholtz-Sloan JS
  Glioblastoma incidence rate trends in Canada and the United States compared with England, 1995-2015 [Kommentar]
  Neuro Oncol 22 (2): 301-302
• 2012, De Bonis P, Doglietto F, Anile C, Pompucci A, Mangiola A
  Electric fields for the treatment of glioblastoma [med. Anw.]
  Expert Rev Neurother 12 (10): 1181-1184
• 2019, de Vocht F
  Analyses of temporal and spatial patterns of glioblastoma multiforme and other brain cancer subtypes in relation to mobile phones using synthetic counterfactuals [epidem.]
  Environ Res 168: 329-335
• 2016, de Vocht F
  [Details] Inferring the 1985-2014 impact of mobile phone use on selected brain cancer subtypes using Bayesian structural time series and synthetic controls [epidem.]
  Environ Int 97: 100-107
• 2021, Dehghani-Soltani S, Eftekhar-Vaghefi SH, Babaee A, Basiri M, Mohammadipoor-Ghasemabad L, Vosough P, Ahmadi-Zeidabadi M
  Pulsed and Discontinuous Electromagnetic Field Exposure Decreases Temozolomide Resistance in Glioblastoma by Modulating the Expression of O6-Methylguanine-DNA Methyltransferase, Cyclin-D1, and p53 [med./bio.]
  Cancer Biother Radiopharm 36 (7): 579-587
• 2023, Deleyrolle LP, Sarkisian MR
  Cilia at the Crossroads of Tumor Treating Fields and Chemotherapy [Review]
  Dev Neurosci 45 (3): 139-146
• 2018, Di Sebastiano AR, Deweyert A, Benoit S, Iredale E, Xu H, de Oliveira C, Wong E, Schmid S, Hebb MO
  Preclinical outcomes of Intratumoral Modulation Therapy for glioblastoma [med./bio.]
  Sci Rep 8: 7301
• 2021, Diamant G, Simchony Goldman H, Gasri Plotnitsky L, Roitman M, Shiloach T, Globerson-Levin A, Eshhar Z, Haim O, Pencovich N, Grossman R, Ram Z, Volovitz I
  T Cells Retain Pivotal Antitumoral Functions under Tumor-Treating Electric Fields [med./bio.]
  J Immunol 207 (2): 709-719
• 2009, Ding GR, Wang XW, Li KC, Qiu LB, Xu SL, Tan J, Guo GZ
  [Details] Comparison of Hsps expression after radio-frequency field exposure in three human glioma cell lines [med./bio.]
  Biomed Environ Sci 22 (5): 374-380
• 2022, Du X, Chen C, Xiao Y, Cui Y, Yang L, Li X, Liu X, Wang R, Tan B
  Research on application of tumor treating fields in glioblastoma: A bibliometric and visual analysis [Review]
  Front Oncol 12: 1055366
• 2014, Elzinga G, Wong ET
  Resolution of cystic enhancement to add-on tumor treating electric fields for recurrent glioblastoma after incomplete response to bevacizumab [med. Anw.]
  Case Rep Neurol 6 (1): 109-115
• 2010, Farina M, Mariggio MA, Pietrangelo T, Stupak JJ, Morini A, Fano G
  [Details] ELF-EMFs induced effects on cell lines: controlling ELF generation in laboratory [med./bio.]
  Progr Electromagn Res B (PIER B) 24: 131-153
• 2019, Fiorentini G, Sarti D, Milandri C, Dentico P, Mambrini A, Fiorentini C, Mattioli G, Casadei V, Guadagni S
  Modulated Electrohyperthermia in Integrative Cancer Treatment for Relapsed Malignant Glioblastoma and Astrocytoma: Retrospective Multicenter Controlled Study [med. Anw.]
  Integr Cancer Ther 18: 1534735418812691
• 2023, Fishman H, Monin R, Dor-On E, Kinzel A, Haber A, Giladi M, Weinberg U, Palti Y
  Tumor Treating Fields (TTFields) increase the effectiveness of temozolomide and lomustine in glioblastoma cell lines [med./bio.]
  J Neurooncol 163 (1): 83-94
• 2012, Fonkem E, Wong ET
  NovoTTF-100A: a new treatment modality for recurrent glioblastoma [med. Anw.]
  Expert Rev Neurother 12 (8): 895-899
• 2022, Foo CY, Munir N, Kumaria A, Akhtar Q, Bullock CJ, Narayanan A, Fu RZ
  Medical Device Advances in the Treatment of Glioblastoma [Review]
  Cancers 14 (21): 5341
• 2019, García-Minguillán López O, Jiménez Valbuena A, Maestú Unturbe C
  Significant Cellular Viability Dependence on Time Exposition at ELF-EMF and RF-EMF In Vitro Studies [med./bio.]
  Int J Environ Res Public Health 16 (12): e2085
• 2021, García-Minguillán O, Maestú C
  [Details] 30 Hz, Could It Be Part of a Window Frequency for Cellular Response? [Review]
  Int J Mol Sci 22 (7): 3642
• 2022, Gentilal N, Abend E, Naveh A, Marciano T, Balin I, Telepinsky Y, Miranda PC
  Temperature and Impedance Variations During Tumor Treating Fields (TTFields) Treatment [tech./dosim.]
  Front Hum Neurosci 16: 931818
• 2021, Gentilal N, Salvador R, Miranda PC
  A Thermal Study of Tumor-Treating Fields for Glioblastoma Therapy [tech./dosim.]
  Brain and Human Body Modeling 2020. Springer, Cham (CH): S. 37-62; ISBN 978-3-030-45622-1
• 2020, Gentilal N, Miranda PC
  Heat transfer during TTFields treatment: Influence of the uncertainty of the electric and thermal parameters on the predicted temperature distribution [tech./dosim.]
  Comput Methods Programs Biomed 196: 105706
• 2019, Gentilal N, Salvador R, Miranda PC
  Temperature control in TTFields therapy of GBM: impact on the duty cycle and tissue temperature [tech./dosim.]
  Phys Med Biol 64 (22): 225008
• 2020, Ghiaseddin AP, Shin D, Melnick K, Tran DD
  Tumor Treating Fields in the Management of Patients with Malignant Gliomas [Grundlagen]
  Curr Treat Options Oncol 21 (9): 76
• 2017, Giladi M, Munster M, Schneiderman RS, Voloshin T, Porat Y, Blat R, Zielinska-Chomej K, Hååg P, Bomzon Z, Kirson ED, Weinberg U, Viktorsson K, Lewensohn R, Palti Y
  Tumor treating fields (TTFields) delay DNA damage repair following radiation treatment of glioma cells [med./bio.]
  Radiat Oncol 12: 206
• 2014, Giladi M, Schneiderman RS, Porat Y, Munster M, Itzhaki A, Mordechovich D, Cahal S, Kirson ED, Weinberg U, Palti Y
  Mitotic disruption and reduced clonogenicity of pancreatic cancer cells in vitro and in vivo by tumor treating fields [med./bio.]
  Pancreatology 14 (1): 54-63
• 2023, Gökçek-Saraç Ç, Şimşek T, Karakurt S
  Cytoprotective effects of low-frequency pulsed electromagnetic field against oxidative stress in glioblastoma cells [med./bio.]
  Gen Physiol Biophys 42 (1): 97-106
• 1997, Goldsmith JR
  [Details] Epidemiologic evidence relevant to radar (microwave) effects [Review]
  Environ Health Perspect 105: 1579-1587
• 2022, Gött H, Kiez S, Dohmen H, Kolodziej M, Stein M
  Tumor treating fields therapy is feasible and safe in a 3-year-old patient with diffuse midline glioma H3K27M - a case report [med. Anw.]
  Childs Nerv Syst 38 (9): 1791-1796
• 2009, Gousias K, Markou M, Voulgaris S, Goussia A, Voulgari P, Bai M, Polyzoidis K, Kyritsis A, Alamanos Y
  [Details] Descriptive epidemiology of cerebral gliomas in northwest Greece and study of potential predisposing factors, 2005-2007 [epidem.]
  Neuroepidemiology 33 (2): 89-95